GE HealthCare Technologies Inc. (NASDAQ:GEHC) finished Wednesday with a subtraction of -$0.01 to close at $73.92, a downside of -0.01 percent. An average of 2,154,980 shares of common stock have been traded in the last five days. There was a fall of -$2.67 in the past week. The last 20 days have seen an average of 3,065,760 shares traded, while the 50-day average volume stands at 3,773,032.
GEHC stock has decreased by -9.03% in the last month. The company shares reached their 1-month lowest point of $73.32 on 08/08/23. Shares of the company touched a low of $53.00 and a high of $87.83 in 52 weeks. It has reached a new high 25 times so far this year and achieved 26.62% or $15.54 in price. In spite of this, the price is down -15.84% from the 52-week high.
Insider Transactions
GEHC stock investors should be aware that GE HealthCare Technologies Inc. (GEHC) stock had its last reported insider trading activity 10 days ago on Jul 31. In this transaction, the insider spent $1,206,949. CEO, Ultrasound, Rott Roland, disposed of 2,473 shares at a price of $77.37 on Jun 08. The insider now owns more than $191,336 worth of shares. Prior to that, CEO, Imaging Makela Jan went on to Sale 70,629 shares at $77.69 each on Mar 14. An amount of $5,487,379 was transacted.
Valuation Metrics
GE HealthCare Technologies Inc. (GEHC) has a trailing price-to-earnings (P/E) ratio of 18.40. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.77, the price-to-book (PB) ratio at 4.74, and the price-to-cash flow ratio at 19.80.
Financial Health
The quick ratio of GE HealthCare Technologies Inc. for the three months ended June 29 was 0.90, and the current ratio was 1.20, indicating that the company is not able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 1.44 and a total debt to equity ratio of 1.44 for the quarter ending June 29. Its gross profit as reported stood at $7.18 billion compared to revenue of $18.34 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, GE HealthCare Technologies Inc.’s return on assets was 6.20%.
Earnings Surprise
For the three-month period that ended June 29, GE HealthCare Technologies Inc. had $10.23 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $418.0 million in the quarter, while revenues were grew 100.0%. The analyst consensus anticipated GE HealthCare Technologies Inc.’s latest quarter earnings to come in at $0.87 per share, but it turned out to be $0.92, a 5.70% surprise. For the quarter, EBITDA amounted to $726.0 million. Shareholders own equity worth $454.84 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at GE HealthCare Technologies Inc. (GEHC) price momentum. RSI 9-day as of the close on 09 August was 20.90%, suggesting the stock is oversold, with historical volatility in this time frame at 14.46%.
As of today, GEHC’s price is $75.07 -3.49% or -$2.67 from its 5-day moving average. GEHC is currently trading -9.51% lower than its 20-day SMA and -3.52% lower than its 100-day SMA. However, the stock’s current price level is -5.75% below the SMA50.
The stochastic %K and %D were 5.86% and 5.13%, respectively, and the average true range (ATR) was 1.65. With the 14-day stochastic at 6.11% and the average true range at 1.69, the RSI (14) stands at 29.54%. The stock has reached -1.69 on the 9-day MACD Oscillator while the 14-day reading was at -2.90.
Analyst Ratings
BofA Securities launched coverage on GE HealthCare Technologies Inc. (NASDAQ: GEHC) in its analyst report released on July 31, 2023. The firm assigned the stock a Neutral rating. The consensus rating for GE HealthCare Technologies Inc. (GEHC) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell GEHC, while 4 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 1 analysts, while 5 others rate it as a “buy”.
What is GEHC’s price target for the next 12 months?
Analysts predict a range of price targets between $78.00 and $99.00, with a median target of $92.00. Taking a look at these predictions, the average price target given by analysts for GE HealthCare Technologies Inc. (GEHC) stock is $89.89.
